Medicines for Radiation Emergencies: Potassium Iodide (KI), Prussian Blue (Radiogardase), Filgrastim (Neupogen), DTPA (Diethylenetriaminepentaacetate) - Drugs for Radiation Exposure

Nonfiction, Health & Well Being, Health, Ailments & Diseases, Cancer, Social & Cultural Studies, Political Science
Cover of the book Medicines for Radiation Emergencies: Potassium Iodide (KI), Prussian Blue (Radiogardase), Filgrastim (Neupogen), DTPA (Diethylenetriaminepentaacetate) - Drugs for Radiation Exposure by Progressive Management, Progressive Management
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Progressive Management ISBN: 9781458072344
Publisher: Progressive Management Publication: March 21, 2011
Imprint: Smashwords Edition Language: English
Author: Progressive Management
ISBN: 9781458072344
Publisher: Progressive Management
Publication: March 21, 2011
Imprint: Smashwords Edition
Language: English

Four important medicines for treatment in radiation emergencies are fully covered in this authoritative collection of official documents: potassium iodide (KI), prussian blue, Filgrastim (Neupogen), and DTPA (Diethylenetriaminepentaacetate). There is detailed information from the FDA, CDC, NRC, and EPA on the use of these medicines.

Potassium iodide is a salt, similar to table salt. Its chemical symbol is KI. It is routinely added to table salt to make it "iodized." Potassium iodide, if taken in time and at the appropriate dosage, blocks the thyroid gland's uptake of radioactive iodine and thus could reduce the risk of thyroid cancers and other diseases that might otherwise be caused by exposure to radioactive iodine that could be dispersed in a severe nuclear accident. Potassium iodide is a special kind of protective measure in that it offers very specialized protection. Potassium iodide protects the thyroid gland against internal uptake of radioiodines that may be released in the unlikely event of a nuclear reactor accident. The purpose of radiological emergency preparedness is to protect people from the effects of radiation exposure after an accident at a nuclear power plant. Evacuation is the most effective protective measure in the event of a radiological emergency because it protects the whole body (including the thyroid gland and other organs) from all radionuclides and all exposure pathways. Administering KI can be a reasonable, prudent, and inexpensive supplement to in-place sheltering and evacuation.

Since the 1960s, Prussian blue has been used to treat people who have been internally contaminated with radioactive cesium (mainly Cs-137) and nonradioactive thallium (once an ingredient in rat poisons). Doctors can prescribe Prussian blue at any point after they have determined that a person who is internally contaminated would benefit from treatment. Prussian blue will help speed up the removal of cesium and thallium from the body. Prussian blue traps radioactive cesium and thallium (mainly Tl-201) in the intestines and keeps them from being re-absorbed by the body. The radioactive materials then move through the intestines and are excreted (passed) in bowel movements. Prussian blue reduces the biological half-life1 of cesium from about 110 days to about 30 days. Prussian blue reduces the biological half-life of thallium from about 8 days to about 3 days. Because Prussian blue reduces the time that radioactive cesium and thallium stay in the body, it helps limit the amount of time the body is exposed to radiation.
When a person has received a very high dose of radiation, destruction of the bone marrow, potentially resulting in uncontrolled bleeding and infection, is a major concern. To help the recovery of the bone marrow, growth factors that stimulate the blood cells to multiply can be used. Filgrastim (trade name Neupogen), is a drug that was approved for use by the FDA in 1991 for cancer patients with bone marrow damage due to chemotherapy or radiotherapy.

DTPA is a kind of medicine called a chelating agent. Chelating agents work by binding and holding on to radioactive materials or poisons that get into the body. Once bound to a radioactive material or poison, the chelating agent is then passed from the body in the urine. Chelating agents help decrease the amount of time it takes to get a poison out of the body.

This is a privately authored news service and educational publication of Progressive Management.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Four important medicines for treatment in radiation emergencies are fully covered in this authoritative collection of official documents: potassium iodide (KI), prussian blue, Filgrastim (Neupogen), and DTPA (Diethylenetriaminepentaacetate). There is detailed information from the FDA, CDC, NRC, and EPA on the use of these medicines.

Potassium iodide is a salt, similar to table salt. Its chemical symbol is KI. It is routinely added to table salt to make it "iodized." Potassium iodide, if taken in time and at the appropriate dosage, blocks the thyroid gland's uptake of radioactive iodine and thus could reduce the risk of thyroid cancers and other diseases that might otherwise be caused by exposure to radioactive iodine that could be dispersed in a severe nuclear accident. Potassium iodide is a special kind of protective measure in that it offers very specialized protection. Potassium iodide protects the thyroid gland against internal uptake of radioiodines that may be released in the unlikely event of a nuclear reactor accident. The purpose of radiological emergency preparedness is to protect people from the effects of radiation exposure after an accident at a nuclear power plant. Evacuation is the most effective protective measure in the event of a radiological emergency because it protects the whole body (including the thyroid gland and other organs) from all radionuclides and all exposure pathways. Administering KI can be a reasonable, prudent, and inexpensive supplement to in-place sheltering and evacuation.

Since the 1960s, Prussian blue has been used to treat people who have been internally contaminated with radioactive cesium (mainly Cs-137) and nonradioactive thallium (once an ingredient in rat poisons). Doctors can prescribe Prussian blue at any point after they have determined that a person who is internally contaminated would benefit from treatment. Prussian blue will help speed up the removal of cesium and thallium from the body. Prussian blue traps radioactive cesium and thallium (mainly Tl-201) in the intestines and keeps them from being re-absorbed by the body. The radioactive materials then move through the intestines and are excreted (passed) in bowel movements. Prussian blue reduces the biological half-life1 of cesium from about 110 days to about 30 days. Prussian blue reduces the biological half-life of thallium from about 8 days to about 3 days. Because Prussian blue reduces the time that radioactive cesium and thallium stay in the body, it helps limit the amount of time the body is exposed to radiation.
When a person has received a very high dose of radiation, destruction of the bone marrow, potentially resulting in uncontrolled bleeding and infection, is a major concern. To help the recovery of the bone marrow, growth factors that stimulate the blood cells to multiply can be used. Filgrastim (trade name Neupogen), is a drug that was approved for use by the FDA in 1991 for cancer patients with bone marrow damage due to chemotherapy or radiotherapy.

DTPA is a kind of medicine called a chelating agent. Chelating agents work by binding and holding on to radioactive materials or poisons that get into the body. Once bound to a radioactive material or poison, the chelating agent is then passed from the body in the urine. Chelating agents help decrease the amount of time it takes to get a poison out of the body.

This is a privately authored news service and educational publication of Progressive Management.

More books from Progressive Management

Cover of the book 21st Century U.S. Military Manuals: Noncombatant Evacuation Operations (FM 90-29) Security, Logistics, Psychological (Value-Added Professional Format Series) by Progressive Management
Cover of the book 21st Century U.S. Military Documents: Air Force U-2 Aircraft - Operations Procedures, Aircrew Evaluation Criteria, Aircrew Training Flying Operations by Progressive Management
Cover of the book Suspended Disbelief: Role of Department of Defense in Interagency Foreign Humanitarian Assistance and Disaster Response – Case Studies of Haiti Earthquake, Super Typhoon Haiyan Operation Damayan by Progressive Management
Cover of the book Air Force Reserve Year in Review, 2015 and 2014: Covers Command, Tenth, Twenty-second, and Fourth Air Force, Yellow Ribbon Program, Global Vigilance with MQ-9 Reaper, 489th Bomb Group's B-1 Lancer by Progressive Management
Cover of the book 2014: The Future of American Airpower - America's Air Force: a Call to the Future, Agile USAF, Naval Aviation Vision 2014-2025, Air-Sea Battle, ISR, UCLASS, X-47B, F-35, 21st Century Deterrence by Progressive Management
Cover of the book Air Force Doctrine Document 3-14.1: Counterspace Operations - Space Situation Awareness, Surveillance, Reconnaissance, Targeting, ISR, GPS, Space Order of Battle by Progressive Management
Cover of the book Challenges in the Asia: Pacific Theater for U.S. and Partner Nation Special Operations Forces - China's Access Denial Doctrine and Capabilities, U.S. and Chinese Military Strengths and Weaknesses by Progressive Management
Cover of the book Apollo and America's Moon Landing Program: Analysis of Apollo 12 Lightning Incident - Technical Report on the Triggered Lightning Strike on the Apollo Saturn V Rocket in 1969 by Progressive Management
Cover of the book Egypt: Federal Research Study with Comprehensive Information, History, and Analysis - Mubarak, NDP, Muslim Brotherhood, Political, Economic, Social, and National Security Systems and Institutions by Progressive Management
Cover of the book 21st Century Pituitary Disorders Sourcebook: Hypopituitarism, Cushing's Syndrome, Combined Pituitary Hormone Deficiency, Acromegaly, Prolactinoma, Tumors, Empty Sella Syndrome, Septo-Optic Dysplasia by Progressive Management
Cover of the book 21st Century U.S. Military Documents: Personnel Readiness and Mobilization (Air Force Handbook 10-416 22) - ANGUS, USAFR, Callup by Progressive Management
Cover of the book Apollo and America's Moon Landing Program: Project Apollo: A Retrospective Analysis - A Narrative Account Starting with the Kennedy Decision, Monograph in Aerospace History by Progressive Management
Cover of the book The United States Army Operating Concept 2016-2028: TRADOC Pam 525-3-1, How the Army Fights, Organizing for Combined Arms Maneuver and Wide Area Security, Training and Education by Progressive Management
Cover of the book Wildland Fire in Ecosystems: Effects of Fire on Cultural Resources and Archaeology (Rainbow Series) Part 3 - Effects on Prehistoric Ceramics, Stone Artifacts, Rock Images, Fire Behavior and Effects by Progressive Management
Cover of the book "All the Missiles Work": Technological Dislocations and Military Innovation - Case Study in U.S. Air Force Air-to-Air Armament, Post-World War II through Rolling Thunder - Vietnam, Guns on Planes by Progressive Management
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy